Oxford Glycosciences - Business Sale

14/04/2003

Celltech, Britain's biggest biotechnology company is likely to take over Oxford Glycosciences (OGS). Celltech may seek a buyer for Zavesca, OGS's treatment for Gauchers disease. The product which is OGS' main asset is thought to be worth £20m.

Acquisitions Related to these Companies

Celltech - Business Sale	24/05/2004
Oxford Glycosciences - Business Sale	14/04/2003
Oxford Glycosciences - Business Sale	24/01/2003
Thiemann / Abgenix - Business Sale	13/09/2001
Celltech - Business Sale	08/09/2000

Other Recent Acquisitions

UK Private Equity Group, Key Capital Par...	06/01/2009
Waterford Wedgwood Has Called In Administrators	05/01/2009
Perfume Retailer Goes Into Administration	05/01/2009
Clydsdale And Yorkshire Banks May Be Sold.	04/01/2009
New Pre-pack Code For Insolvency Practitioners	04/01/2009

Subscribe now to get advanced acquisition search capabilities.

Acquisitions Related to these Companies

Other Recent Acquisitions

Business for Sale Search